LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway

Luo, Mengmeng; Lei, Rui; Zhao, Qingfang; Shen, Yichen; He, Zhigang; Xu, Jinghong

doi:10.7150/ijms.84072



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2024; 21(2):265-276. doi:10.7150/ijms.84072 This issue Cite

Research Paper

LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway

Mengmeng Luo, M.D., Rui Lei, M.D., Qingfang Zhao, M.D., Yichen Shen, M.D., Zhigang He, Ph.D.^✉, Jinghong Xu, M.D.^✉

Department of Plastic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University; Hangzhou, China.

Citation:

Luo M, Lei R, Zhao Q, Shen Y, He Z, Xu J. LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway. Int J Med Sci 2024; 21(2):265-276. doi:10.7150/ijms.84072. https://www.medsci.org/v21p0265.htm

Other styles

Abstract

Melanoma is a highly malignant tumor in the body. Long non-coding RNAs (lncRNAs) have been reported to be involved in the development of various tumors. Emerging evidence demonstrates the critical role of lncRNAs in melanoma development. In this study, we aimed to investigate the expression, biological function and regulatory mechanism of LINC00662 in melanomas. First, we found that LINC00662 was up-regulated in melanoma tissues and cell lines. High expression of LINC00662 in melanomas was associated with a poor patient prognosis. Silencing of LINC00662 suppressed the proliferation, migration, and invasion of melanoma cells in vitro and in vivo, while overexpression of LINC00662 promoted melanoma cell proliferation in vitro. Bioinformatics analysis, dual-luciferase assay, and RIP assay confirmed that LINC00662 competitively regulated miR-107. Silencing of LINC00662 upregulated miR-107 expression in a melanoma cell line. Inhibition of miR-107 significantly reversed the inhibitory effect of LINC00662 silencing on cell proliferation and migration. Furthermore, POU3F2 was validated as a downstream target of LINC00662/miR107 and was downregulated when LINC00662 was silenced. Overexpressing POU3F2 attenuated the effect of si-LINC00662 on cellular functions. In addition, the results also showed that the β-catenin pathway was involved in a si-LINC00662-induced function in melanoma. Overall, our results confirmed that LINC00662 promoted melanoma progression by sponging miR107 and inducing POU3F2, highlighting the mechanism of the LINC00662/miR-107/POU3F2 axis in melanoma cell proliferation and invasion.

Keywords: Melanoma, LINC00662, MiR-107, POU3F2

Citation styles

APA

Luo, M., Lei, R., Zhao, Q., Shen, Y., He, Z., Xu, J. (2024). LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway. International Journal of Medical Sciences, 21(2), 265-276. https://doi.org/10.7150/ijms.84072.

ACS

Luo, M.; Lei, R.; Zhao, Q.; Shen, Y.; He, Z.; Xu, J. LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway. Int. J. Med. Sci. 2024, 21 (2), 265-276. DOI: 10.7150/ijms.84072.

NLM

CSE

Luo M, Lei R, Zhao Q, Shen Y, He Z, Xu J. 2024. LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway. Int J Med Sci. 21(2):265-276.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.